Loss of microRNAs in thymus perturbs invariant NKT cell development and function

Cellular and Molecular Immunology

Volumn 7, Issue 6, 2010, Pages 447-453

  Seo, Kook Heon ^a   Zhou, Li ^a   Meng, Dongmei ^b,c   Xu, Jianrui ^b   Dong, Zhong ^b   Mi, Qing Sheng ^a  

^a HENRY FORD HEALTH SYSTEM   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

^c QINGDAO UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

autoimmunity; development; iNKT cells; microRNAs

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; CD1D ANTIGEN; DICER; HERMES ANTIGEN; MICRORNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL MATURATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE DELETION; GENE FUNCTION; GENE LOSS; GENOTYPE; IMMUNE DYSREGULATION; IMMUNOREGULATION; INTRACELLULAR SIGNALING; LOSS OF FUNCTION MUTATION; LYMPHOCYTE COUNT; LYMPHOCYTE FUNCTION; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PROTEIN EXPRESSION; RNA INTERFERENCE; T LYMPHOCYTE ACTIVATION; THYMUS;

ANIMALS; ANTIGENS, CD1D; DEAD-BOX RNA HELICASES; ENDORIBONUCLEASES; HOMEOSTASIS; LYMPHOCYTE COUNT; MICE; MICE, KNOCKOUT; MICRORNAS; NATURAL KILLER T-CELLS; THYMUS GLAND;

EID: 79951662541     PISSN: 16727681     EISSN: None     Source Type: Journal    
DOI: 10.1038/cmi.2010.49     Document Type: Article

References (30)

1. Sharif S, Arreaza GA, Zucker P, Mi QS, Sondhi J, Naidenko OV et al. Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes. Nat Med 2001;7:1057-1062. (Pubitemid 32937388)
2. Miyake S, Yamamura T. NKT cells and autoimmune diseases: unraveling the complexity. Curr Top Microbiol Immunol 2007;314:251-267.
3. Godfrey DI, Berzins SP. Control points in NKT-cell development. Nat Rev Immunol 2007;7:505-518. (Pubitemid 46987785)
4. Van KL. NKT cells: T lymphocytes with innate effector functions. Curr Opin Immunol 2007;19:354-364.
5. Mi QS, Meagher C, Delovitch TL. CD1d-restricted NKT regulatory cells: functional genomic analyses provide new insights into the mechanisms of protection against Type 1 diabetes. Novartis Found Symp 2003;252:146-160.
6. Mi QS, Ly D, Zucker P, McGarry M, Delovitch TL. Interleukin-4 but not interleukin-10 protects against spontaneous and recurrent Type 1 diabetes by activated CD1drestricted invariant natural killer T-cells. Diabetes 2004;53:1303-1310. (Pubitemid 38569017)
7. Kronenberg M, Engel I. On the road: progress in finding the unique pathway of invariant NKT cell differentiation. Curr Opin Immunol 2007;19:186-193. (Pubitemid 46356970)
8. Kronenberg M, Gapin L. Natural killer T cells: know thyself. Proc Natl Acad Sci USA 2007;104:5713-5714. (Pubitemid 47175599)
9. Tupin E, Kinjo Y, Kronenberg M. The unique role of natural killer T cells in the response to microorganisms. Nat Rev Microbiol 2007;5:405-417. (Pubitemid 46780078)
10. Bendelac A, Savage PB, Teyton L. The biology of NKT cells. Annu Rev Immunol 2007;25:297-336. (Pubitemid 46697911)
11. Borowski C, Bendelac A. Signaling for NKT cell development: the SAP-FynT connection. J Exp Med 2005;201:833-836. (Pubitemid 40524451)
12. Savage AK, Constantinides MG, Han J, Picard D, Martin E, Li B et al. The transcription factor PLZF directs the effector program of the NKT cell lineage. Immunity 2008;29:391-403.
13. Zhou L, Seo KH, Wong HK, Mi QS. MicroRNAs and immune regulatory T cells. Int Immunopharmacol 2009;9:524-527.
14. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004;116:281-297.
15. Chen CZ, Li L, Lodish HF, Bartel DP. MicroRNAs modulate hematopoietic lineage differentiation. Science 2004;303:83-86. (Pubitemid 38055775)
16. Cobb BS, Nesterova TB, Thompson E, Hertweck A, O'Connor E, Godwin J et al. T cell lineage choice and differentiation in the absence of the RNase III enzyme Dicer. J Exp Med 2005;201:1367-1373. (Pubitemid 40664081)
17. Muljo SA, Ansel KM, Kanellopoulou C, Livingston DM, Rao R, Rajewsky K. Aberrant T cell differentiation in the absence of Dicer. J Exp Med 2005;202:261-269. (Pubitemid 41043822)
18. Bernstein E, Kim SY, Carmell MA, Murchison EP, Alcorn H, Li MZ et al. Dicer is essential for mouse development. Nat Genet 2003;35:215-217. (Pubitemid 37363172)
19. Suarez Y, Fernández-Hernando C, Yu J, Gerber SA, Harrison KD, Pober JS et al. Dicerdependent endothelial microRNAs are necessary for postnatal angiogenesis. Proc Natl Acad Sci USA 2008;105:14082-14087.
20. Koralov SB, Muljo SA, Galler GR, Krek A, Chakraborty T, Kanellopoulou C et al. Dicer ablation affects antibody diversity and cell survival in the B lymphocyte lineage. Cell 2008;132:860-874. (Pubitemid 351312808)
21. Mizoguchi F, Izu Y, Hayata T, Hemmi H, Nakashima K, Nakamura T et al. Osteoclastspecific Dicer gene deficiency suppresses osteoclastic bone resorption. J Cell Biochem 2009;109:866-875.
22. Cobb BS, Nesterova TB, Thompson E, Hertweck A, O'Connor E, Godwin J et al. A role for Dicer in immune regulation. J Exp Med 2006;203:2519-2527. (Pubitemid 44664621)
23. Liston A, Lu LF, O'Carroll D, Tarakhovsky A, Rudensky AY. Dicer-dependent microRNA pathway safeguards regulatory T cell function. J Exp Med 2008;205:1993-2004.
24. Zhou X, Jeker LT, Fife BT, Zhu S, Anderson MS, McManus MT et al. Selective miRNA disruption in T reg cells leads to uncontrolled autoimmunity. J Exp Med 2008;205:1983-1991.
25. Zhou L, Seo KH, He HZ, Pacholczyk R, Meng DM, Li CG et al. Tie2cre-induced inactivation of the miRNA-processing enzyme Dicer disrupts invariant NKT cell development. Proc Natl Acad Sci USA 2009;106:10266-10271.
26. Harfe BD, McManus MT, Mansfield JH, Hornstein E, Tabin CJ. The RNaseIII enzyme Dicer is required for morphogenesis but not patterning of the vertebrate limb. Proc Natl Acad Sci USA 2005;102:10898-10903. (Pubitemid 41105964)
27. Fedeli M, Napolitano A, Wong MP, Marcais A, de Lalla C, Colucci F et al. Dicerdependent microRNA pathway controls invariant NKT cell development. J Immunol 2009;183:2506-2512.
28. Gapin L, Matsuda JL, Surh CD, Kronenberg M. NKT cells derive from double-positive thymocytes that are positively selected by CD1d. Nat Immunol 2001;2:971-978. (Pubitemid 32976171)
29. Benlagha K, Wei DG, Veiga J, Teyton L, Bendelac A. Characterization of the early stages of thymic NKT cell development. J Exp Med 2005;202:485-492. (Pubitemid 41186947)
30. Kim PJ, Pai SY, Brigl M, Besra GS, Gumperz J, Ho IC. GATA-3 regulates the development and function of invariant NKT cells. J Immunol 2006;177:6650-6659. (Pubitemid 44715028)